Akita, Koji <br/><br/>
Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice.  [electronic resource] 

 -  Journal of the American Heart Association  Mar 2015 
 - e001469 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.114.001469  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Arteritis--enzymology<br/>Atherosclerosis--enzymology<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Cell Proliferation--drug effects<br/>Chemokine CCL2--metabolism<br/>Cholesterol--blood<br/>Dipeptidyl Peptidase 4--metabolism<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Disease Models, Animal<br/>Femoral Artery--drug effects<br/>Glucagon-Like Peptide 1--blood<br/>Inflammation Mediators--metabolism<br/>Interleukin-1beta--metabolism<br/>Male<br/>Mice, Knockout<br/>NF-kappa B--metabolism<br/>Neointima<br/>Phosphorylation<br/>Piperidines--pharmacology<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Receptors, LDL--deficiency<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Uracil--analogs & derivatives<br/>Vascular System Injuries--drug therapy